THU0623 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib in Patients with Early Rheumatoid Arthritis Who Had Received Limited or No Treatment with Disease-Modifying anti-Rheumatic Drugs: Table 1.

M. Schiff; T. Takeuchi; C. Gaich; A.M. DeLozier; D. Schlichting; W.-L. Kuo; P. Durez; T. Carmack; J.-E. Won; R. Fleischmann

doi:10.1136/annrheumdis-2016-eular.1248

THU0623 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib in Patients with Early Rheumatoid Arthritis Who Had Received Limited or No Treatment with Disease-Modifying anti-Rheumatic Drugs: Table 1.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.1248 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 419.1-419 ◽

Cited By ~ 2

Author(s):

M. Schiff ◽

T. Takeuchi ◽

C. Gaich ◽

A.M. DeLozier ◽

D. Schlichting ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Early Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Phase 3 ◽

Patient Reported ◽

Disease Modifying

Download Full-text

SAT0165 Improvements in Patient-Reported Outcomes and Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naïve Early Rheumatoid Arthritis Patients: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.1499 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 712.2-713 ◽

Cited By ~ 1

Author(s):

P. Emery ◽

C.O. Bingham ◽

G.-R. Burmester ◽

V.P. Bykerk ◽

D.E. Furst ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Early Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Certolizumab Pegol ◽

Phase 3 ◽

Double Blind ◽

Patient Reported ◽

Household Productivity

Download Full-text

Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial

International Journal of Rheumatic Diseases ◽

10.1111/1756-185x.13244 ◽

2018 ◽

Vol 21 (2) ◽

pp. 402-414 ◽

Cited By ~ 7

Author(s):

Zhanguo Li ◽

Yuan An ◽

Houheng Su ◽

Xiangpei Li ◽

Jianhua Xu ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Chinese Patients ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Phase 3 ◽

Randomized Controlled ◽

Patient Reported ◽

Disease Modifying

Download Full-text

THU0609 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Background Methotrexate Therapy: Table 1.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.1239 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 412.2-413 ◽

Cited By ~ 1

Author(s):

E. Keystone ◽

P. Taylor ◽

Y. Tanaka ◽

C. Gaich ◽

A.M. DeLozier ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Active Rheumatoid Arthritis ◽

Methotrexate Therapy ◽

Inadequate Response ◽

Phase 3 ◽

Patient Reported

Download Full-text

Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice

Clinical Rheumatology ◽

10.1007/s10067-017-3962-5 ◽

2018 ◽

Vol 37 (5) ◽

pp. 1189-1197 ◽

Cited By ~ 19

Author(s):

G. A. Versteeg ◽

L. M. M. Steunebrink ◽

H. E. Vonkeman ◽

P. M. ten Klooster ◽

A. E. van der Bijl ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Early Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Daily Clinical Practice ◽

Treat To Target ◽

Patient Reported

Download Full-text

The Relation Between Disease Activity, Patient‐Reported Outcomes, and Grip Force Over Time in Early Rheumatoid Arthritis

ACR Open Rheumatology ◽

10.1002/acr2.11062 ◽

2019 ◽

Vol 1 (8) ◽

pp. 507-515

Author(s):

Maria Rydholm ◽

Ingegerd Wikström ◽

Sofia Hagel ◽

Lennart T. H. Jacobsson ◽

Carl Turesson

Keyword(s):

Rheumatoid Arthritis ◽

Disease Activity ◽

Early Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Grip Force ◽

Patient Reported ◽

Over Time

Download Full-text

O10 In early rheumatoid arthritis, trajectory of DAS28 progression is associated with poor patient reported outcomes: results from the SERA study

Rheumatology ◽

10.1093/rheumatology/kez105.009 ◽

2019 ◽

Vol 58 (Supplement_3) ◽

Author(s):

James Dale ◽

Katie Druce ◽

Duncan Porter ◽

Keyword(s):

Rheumatoid Arthritis ◽

Early Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Poor Patient ◽

Patient Reported

Download Full-text

Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment

Arthritis Research & Therapy ◽

10.1186/s13075-017-1410-1 ◽

2017 ◽

Vol 19 (1) ◽

Cited By ~ 17

Author(s):

Michael Schiff ◽

Tsutomu Takeuchi ◽

Roy Fleischmann ◽

Carol L. Gaich ◽

Amy M. DeLozier ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Treatment ◽

Patient Reported Outcomes ◽

Antirheumatic Drug ◽

Patient Reported ◽

Disease Modifying ◽

Disease Modifying Antirheumatic Drug

Download Full-text

SAT0543 Reduced/Withdrawn Dose of Etanercept-Methotrexate Therapy of Early Rheumatoid Arthritis has a Favorable Impact on Patient-Reported Outcomes Compared with MTX Alone or Placebo: the Prize Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.2267 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A765.3-A766

Author(s):

P. Emery ◽

P. Wiland ◽

J. Dudler ◽

R. M. Ionescu ◽

B. Vlahos ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Early Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Methotrexate Therapy ◽

Patient Reported

Download Full-text

Evaluating patient reported outcomes in routine practice of patients with rheumatoid arthritis treated with biological disease modifying anti rheumatic drugs (b-DMARDs)

SpringerPlus ◽

10.1186/s40064-015-1247-5 ◽

2015 ◽

Vol 4 (1) ◽

Cited By ~ 3

Author(s):

Niels W. Boone ◽

Patty Teeuwisse ◽

Paul-Hugo van der Kuy ◽

Rob Janknegt ◽

Robert B. M. Landewé

Keyword(s):

Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Routine Practice ◽

Patient Reported ◽

Disease Modifying

Download Full-text

SAT0226 Tocilizumab (TCZ) as Combination Therapy and as Monotherapy VS Methotrexate (MTX) in MTX-Naive Patients with Early Rheumatoid Arthritis: Patient-Reported Outcomes (PROS) from A Randomized, Placebo-Controlled Trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.2178 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 672.1-672 ◽

Cited By ~ 1

Author(s):

G. Burmester ◽

R. Blanco ◽

M. Keiserman ◽

W. Rigby ◽

R.F. van Vollenhoven ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Rheumatoid Arthritis Patient ◽

Combination Therapy ◽

Early Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Early Rheumatoid Arthritis Patient ◽

Patient Reported

Download Full-text